Skip to content

Clinical study for hemorrhoid varicose vein sclerotherapy

Clinical study for hemorrhoid varicose vein sclerotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026421
Enrollment
Unknown
Registered
2019-10-09
Start date
2019-10-15
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoid varicose veins

Interventions

single arm:foam sclerotherapy

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Between the ages of 18 and 75 years, Internal hemorrhoid hemorrhage was the typical symptom, Informed consent has been signed.

Exclusion criteria

Exclusion criteria: Patients with acute anal inflammation, acute perianal thrombosis, fecal incontinence, anal fistula and anal fissure, patients with proctitis, perianal abscess, anal eczema and acute severe systemic diseases, patients who have been sclerotherapy for hemorrhoids within 12 months.

Design outcomes

Primary

MeasureTime frame
Improvement of hemorrhoid varicose veins;Postoperative bleeding rate;the incidence of complications;

Countries

China

Contacts

Public ContactDerun Kong

The First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026